Dar Al Dawa Development and Investment (AMM:DADI) 3-Year Revenue Growth Rate : 0.20% (As of Mar. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Dar Al Dawa Development and Investment 3-Year Revenue Growth Rate?

Dar Al Dawa Development and Investment's Revenue per Share for the three months ended in Mar. 2024 was JOD0.39.

During the past 12 months, Dar Al Dawa Development and Investment's average Revenue per Share Growth Rate was 20.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was -2.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was -3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Dar Al Dawa Development and Investment was 20.80% per year. The lowest was -10.40% per year. And the median was 0.20% per year.

Competitive Comparison of Dar Al Dawa Development and Investment's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al Dawa Development and Investment's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dar Al Dawa Development and Investment's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dar Al Dawa Development and Investment's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Dar Al Dawa Development and Investment's 3-Year Revenue Growth Rate falls into.

Dar Al Dawa Development and Investment 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Dar Al Dawa Development and Investment (AMM:DADI) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Dar Al Dawa Development and Investment 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Dar Al Dawa Development and Investment's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dar Al Dawa Development and Investment (AMM:DADI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al Dawa Development and Investment (AMM:DADI) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Naour, P.O. Box 9364, Amman, JOR, 11191

Website

https://www.dadgroup.com

Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives of the company are to manufacture pharmaceutical, chemical, pharmaceutical, and related products and to import medicines. It offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.

Dar Al Dawa Development and Investment (AMM:DADI) Headlines

No Headlines